Product Code: GVR-2-68038-323-2
Urology Surgical Instruments Market Summary
The global urology surgical instruments market size was estimated at USD 12.88 billion in 2024 and is expected to reach USD 25.24 billion by 2033, growing at a CAGR of 7.52% from 2025 to 2033. The urology surgical instruments market is expanding rapidly due to numerous factors, including the rising geriatric population and the increasing prevalence of urological problems such as kidney stones, involuntary leakage of urine (urinary incontinence), benign prostatic hyperplasia (BPH, or enlarged prostate), and cancers affecting the urinary system.
These disorders necessitate surgical intervention, which increases the demand for urological surgical instruments. The growing burden of benign prostatic hyperplasia (BPH) is expected to drive the demand for urology surgical instruments significantly in the coming years. Surgical instruments, such as catheters, play a crucial role in the management of BPH by providing immediate relief from urinary symptoms and significantly enhancing patients' quality of life. In individuals with BPH, urinary catheters offer a direct pathway for urine to exit the body, effectively bypassing the blockage caused by an enlarged prostate. Due to their essential role in symptom management and patient care, the rising prevalence of BPH is anticipated to contribute to an increased demand for surgical instruments.
Furthermore, prostate cancer is one of the most commonly diagnosed cancers in men, leading to a growing number of surgical interventions such as prostatectomies and biopsies. This rising volume of procedures drives increased demand for advanced urological surgical instruments, including minimally invasive and robotic-assisted technologies. According to data published by the Indian Journal of Urology in September 2024, prostate cancer is the second most common cancer among males across the globe, accounting for approximately 14.2% of all new cancer cases in men, with an age-adjusted incidence rate of 29.4 per 100,000 population. In addition, urinary incontinence is a common complication following prostate cancer surgery, often resulting from nerve and muscle damage around the bladder. As a result, treatments such as urethral slings and artificial urinary sphincters are increasingly used to manage post-surgical urinary incontinence.
Moreover, the rapidly aging global population is a major factor driving the growth of the urological surgical instruments market, as age-related conditions like benign prostatic hyperplasia (BPH), urinary incontinence, prostate cancer, and kidney stones become increasingly common in older adults. As the number of seniors increases, the demand for diagnostic assessments and surgical interventions to restore urinary function and enhance quality of life rises. This demographic shift is prompting hospitals and surgical centers to expand their urological services and adopt advanced, surgical instruments that offer faster recovery and reduced complications.
Global Urology Surgical Instruments Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global urology surgical instruments market on the basis of product, application, and region:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Endoscopes
- Laparoscopes
- Ureteroscopes
- Nephroscopes
- Resectoscopes
- Cystoscopes
- Envision Systems
- Light Sources
- Cameras
- Camera Heads
- Monitors & Displays
- Peripheral Systems
- Insufflators
- Endoscopy Fluid Flushing Devices
- Consumables & Accessories
- Guidewires
- Stone Baskets/Retrieval Devices and Extractors
- Catheters
- Stents
- Biopsy Devices
- Fluid Flushing Devices, Connecting Tubes, Clamps, Overtubes, and Distal Attachments
- Dilator Sets and Ureteral Access Sheaths
- Drainage Bags
- Surgical Dissectors
- Needle Forceps and Needle Holders
- Others
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Chronic Kidney Diseases (CKD)
- Benign Prostatic Hyperplasia (BPH)
- Urinary Stones
- Urinary Incontinence (UI) and Pelvic Organ Prolapse (POP)
- Oncology
- Other Applications
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- MEA
- South Africa
- UAE
- Kuwait
- Saudi Arabia
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Urology Surgical Instruments Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising Prevalence of Urological Disorders
- 3.2.1.2. Growing Geriatric Population
- 3.2.1.3. Expansion of Healthcare Infrastructure
- 3.2.2. Market restraint analysis
- 3.2.2.1. High Cost of Advanced Instruments
- 3.2.3. Market opportunity analysis
- 3.2.3.1. Advancements in Minimally Invasive Surgery
- 3.2.3.2. Rising Patient Awareness
- 3.2.3.3. Technological advancements
- 3.2.4. Market challenges analysis
- 3.2.4.1. Competition from Non-Surgical Treatments
- 3.3. Urology Surgical Instruments Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Urology Surgical Instruments: Product Estimates & Trend Analysis
- 4.1. Urology Surgical Instruments Market: Key Takeaways
- 4.2. Urology Surgical Instruments Market: Movement & Market Share Analysis, 2021 & 2033
- 4.3. Endoscopes
- 4.3.1. Endoscopes market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.3.1.1. Laparoscopes
- 4.3.1.1.1. Laparoscopes market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.3.1.2. Ureteroscopes
- 4.3.1.2.1. Ureteroscopes market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.3.1.3. Nephroscopes
- 4.3.1.3.1. Nephroscopes market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.3.1.4. Resectoscopes
- 4.3.1.4.1. Resectoscopes market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.3.1.5. Cystoscopes
- 4.3.1.5.1. Cystoscopes market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.4. Endovision Systems
- 4.4.1. Endovision systems market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.4.1.1. Light Sources
- 4.4.1.1.1. Light sources market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.4.1.2. Cameras
- 4.4.1.2.1. Cameras market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.4.1.3. Camera Heads
- 4.4.1.3.1. Camera heads market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.4.1.4. Monitors & Displays
- 4.4.1.4.1. Monitors & displays market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.5. Peripheral Systems
- 4.5.1. Peripheral systems market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.5.1.1. Insufflators
- 4.5.1.1.1. Insufflators market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.5.1.2. Endoscopy Fluid Flushing Devices
- 4.5.1.2.1. Endoscopy fluid flushing devices market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6. Accessories & Consumables
- 4.6.1. Accessories & consumables market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6.1.1. Guidewires
- 4.6.1.1.1. Guidewires market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6.1.2. Stone Baskets/Retrieval Devices and Extractors
- 4.6.1.2.1. Stone baskets/retrieval devices and extractors market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6.1.3. Catheters
- 4.6.1.3.1. Catheters market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6.1.4. Stents
- 4.6.1.4.1. Stents market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6.1.5. Biopsy Devices
- 4.6.1.5.1. Biopsy devices market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6.1.6. Fluid Flushing Devices, Connecting Tubes, Clamps, Overtubes, and Distal Attachments
- 4.6.1.6.1. Fluid flushing devices, connecting tubes, clamps, overtubes, and distal attachments market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6.1.7. Dilator Sets and Ureteral Access Sheaths
- 4.6.1.7.1. Dilator sets and ureteral access sheaths market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6.1.8. Drainage Bags
- 4.6.1.8.1. Drainage bags market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6.1.9. Surgical Dissectors
- 4.6.1.9.1. Surgical dissectors market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6.1.10. Needle Forceps and Needle Holders
- 4.6.1.10.1. Needle forceps and needle holders market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.6.1.11. Others
- 4.6.1.11.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 5. Urology Surgical Instruments: Application Estimates & Trend Analysis
- 5.1. Urology Surgical Instruments Market: Key Takeaways
- 5.2. Urology Surgical Instruments Market: Movement & Market Share Analysis, 2021 & 2033
- 5.3. Chronic Kidney Disease
- 5.3.1. Chronic kidney disease market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.4. Benign Prostatic Hyperplasia (BPH)
- 5.4.1. Benign Prostatic Hyperplasia (BPH) market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.5. Urinary Stones
- 5.5.1. Urinary stones market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.6. Urinary Incontinence (UI) and Pelvic Organ Prolapse (POP)
- 5.6.1. Urinary Incontinence (UI) and Pelvic Organ Prolapse (POP) market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.7. Oncology
- 5.7.1. Oncology market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.8. Other Applications
- 5.8.1. Other applications market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 6. Urology Surgical Instruments Market: Regional Estimates & Trend Analysis
- 6.1. Regional Outlook
- 6.2. Urology Surgical Instruments Market by Region: Key Marketplace Takeaway
- 6.3. North America
- 6.3.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.3.2. U.S.
- 6.3.2.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.3.3. Canada
- 6.3.3.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.3.4. Mexico
- 6.3.4.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.4. Europe
- 6.4.1. UK
- 6.4.1.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.4.2. Germany
- 6.4.2.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.4.3. France
- 6.4.3.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.4.4. Italy
- 6.4.4.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.4.5. Spain
- 6.4.5.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.4.6. Sweden
- 6.4.6.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.4.7. Norway
- 6.4.7.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.4.8. Denmark
- 6.4.8.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.5. Asia Pacific
- 6.5.1. Japan
- 6.5.1.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.5.2. China
- 6.5.2.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.5.3. India
- 6.5.3.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.5.4. Australia
- 6.5.4.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.5.5. Thailand
- 6.5.5.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.5.6. South Korea
- 6.5.6.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.6. Latin America
- 6.6.1. Brazil
- 6.6.1.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.6.2. Argentina
- 6.6.2.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.7. MEA
- 6.7.1. Saudi Arabia
- 6.7.1.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.7.2. South Africa
- 6.7.2.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.7.3. UAE
- 6.7.3.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
- 6.7.4. Kuwait
- 6.7.4.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Market Participant Categorization
- 7.2.1. Medtronic
- 7.2.1.1. Company overview
- 7.2.1.2. Financial performance
- 7.2.1.3. Product benchmarking
- 7.2.1.4. Strategic initiatives
- 7.2.2. Boston Scientific Corporation
- 7.2.2.1. Company overview
- 7.2.2.2. Financial performance
- 7.2.2.3. Product benchmarking
- 7.2.2.4. Strategic initiatives
- 7.2.3. Olympus America
- 7.2.3.1. Company overview
- 7.2.3.2. Financial performance
- 7.2.3.3. Product benchmarking
- 7.2.3.4. Strategic initiatives
- 7.2.4. KARL STORZ
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. Cook
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. Richard Wolf GmbH
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. Stryker
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. Teleflex Incorporated
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives
- 7.2.9. Advin Urology
- 7.2.9.1. Company overview
- 7.2.9.2. Financial performance
- 7.2.9.3. Product benchmarking
- 7.2.9.4. Strategic initiatives